Filter Results
:
(51)
Show Results For
-
All HBS Web
(182)
- Faculty Publications (51)
Show Results For
-
All HBS Web
(182)
- Faculty Publications (51)
←
Page 3 of
51
Results
- November 2008
- Journal Article
Can Research Committees Add Value for Investors? An Analysis of Lehman Brothers' Ten Uncommon Values® Recommendations
By: Boris Groysberg, Paul M. Healy and Yang Gui
Since 1949 Lehman Brothers has used an investment committee to select the top ten recommendations made by its analysts each year. We examine the performance of this committee's recommendations and find that on average its selections generated abnormal returns of 2.7%...
View Details
Keywords:
Forecasting and Prediction;
Stocks;
Financial Markets;
Investment;
Investment Return;
Governing Rules, Regulations, and Reforms;
Performance Expectations;
Groups and Teams;
Research;
Value Creation
Groysberg, Boris, Paul M. Healy, and Yang Gui. "Can Research Committees Add Value for Investors? An Analysis of Lehman Brothers' Ten Uncommon Values® Recommendations." Journal of Financial Transformation 24 (November 2008): 123–130.
- 2008
- Working Paper
CEO and CFO Career Penalties to Missing Quarterly Analysts Forecasts
By: Rick Mergenthaler, Shiva Rajgopal and Suraj Srinivasan
We find that missing the quarterly analyst consensus earnings forecast is associated with career penalties in the form of a reduced bonus, smaller equity grants, and a greater chance of forced dismissal for both CEOs and CFOs during the period 1993-2004. These results...
View Details
Keywords:
Earnings Management;
Governing and Advisory Boards;
Compensation and Benefits;
Managerial Roles;
Personal Development and Career
Mergenthaler, Rick, Shiva Rajgopal, and Suraj Srinivasan. "CEO and CFO Career Penalties to Missing Quarterly Analysts Forecasts." Harvard Business School Working Paper, No. 09-014, August 2008. (Revised June 2009.)
- July – August 2008
- Article
Buy-Side vs. Sell-Side Analysts' Earnings Forecasts
By: Boris Groysberg, Paul M. Healy and Craig James Chapman
We compare the earnings forecast performance of analysts at a large buy-side firm to that of sell-side analysts. Our tests show that the buy-side firm analysts make more optimistic and less accurate forecasts than their counterparts on the sell-side. These performance...
View Details
Keywords:
Motivation and Incentives;
Business Earnings;
Forecasting and Prediction;
Performance Effectiveness
Groysberg, Boris, Paul M. Healy, and Craig James Chapman. "Buy-Side vs. Sell-Side Analysts' Earnings Forecasts ." Financial Analysts Journal 64, no. 4 (July–August 2008): 25 – 39.
- November 2006 (Revised March 2008)
- Case
Kendall Square Research Corporation
Kendall Square Research was a small competitor in the supercomputer industry. Sales grew rapidly in 1992 and early 1993 and the company sold stock to the public for the first time. Analysts forecast higher earnings for 1993, then the company's revenue recognition...
View Details
McFarlan, F. Warren. "Kendall Square Research Corporation." Harvard Business School Case 307-010, November 2006. (Revised March 2008.)
- May 2006
- Case
Nokia in 2003
By: Paul M. Healy
Examines the challenges facing a money manager who owns stock in Nokia, the leading wireless handset provider. Two analysts covering the stock make very different predictions about the economies of the industry, Nokia's future performance, and stock recommendations....
View Details
- February 2006 (Revised August 2006)
- Case
Kevin McCarthy and Westlake Chemical Corporation (A)
By: Edward J. Riedl
Examines forecasting earnings/performance for a commodity chemical firm during a period of high uncertainty, highlighting the combined effects of input process (natural gas), industry capacity/utilization, and cyclicality. Assuming the role of Kevin McCarthy (the top...
View Details
Keywords:
Risk and Uncertainty;
Futures and Commodity Futures;
Forecasting and Prediction;
Chemicals;
Chemical Industry
Riedl, Edward J. "Kevin McCarthy and Westlake Chemical Corporation (A)." Harvard Business School Case 106-049, February 2006. (Revised August 2006.)
- July 2002 (Revised March 2005)
- Case
Kendall Square Research Corporation (A) (Abridged)
By: William J. Bruns Jr. and F. Warren McFarlan
Kendall Square Research was a small competitor in the supercomputer industry. Sales grew rapidly in 1992 and early 1993, and the company sold stock to the public for the first time. Analysts forecasted higher earnings for 1993, then the company's revenue recognition...
View Details
Bruns, William J., Jr., and F. Warren McFarlan. "Kendall Square Research Corporation (A) (Abridged)." Harvard Business School Case 303-036, July 2002. (Revised March 2005.)
- April 2002 (Revised July 2002)
- Case
Imagicast
By: John T. Gourville and Alison Berkley Wagonfeld
Imagicast has brought to market an interactive, multimedia retail kiosk designed to increase product sales. In spite of promising projections by industry analysts and detailed demand forecasts by Imagicast management, the company has yet to sell a single kiosk. Time...
View Details
Keywords:
Forecasting and Prediction;
Crisis Management;
Product Launch;
Demand and Consumers;
Sales;
Technology;
Retail Industry;
United States
Gourville, John T., and Alison Berkley Wagonfeld. "Imagicast." Harvard Business School Case 502-052, April 2002. (Revised July 2002.)
- Article
End the Mythmaking and Return to True Analysis
By: Joseph B. Fuller
Fuller, Joseph B. "End the Mythmaking and Return to True Analysis." Financial Times (January 22, 2002).
- January 2001 (Revised July 2003)
- Case
Pharmacyclics: Financing Research & Development
By: Malcolm P. Baker, Richard S. Ruback and Aldo Sesia
Pharmacyclics (NASDAQ: PCYC), a pharmaceutical company that manufactures products that will improve existing therapeutic treatments for cancer, arteriosclerosis, and retinal disease, was considering a $60 million private placement in February 2000. The company had more...
View Details
Keywords:
Valuation;
Cash Flow;
Financing and Loans;
Business Startups;
Financial Strategy;
Medical Devices and Supplies Industry;
Pharmaceutical Industry;
Health Industry
Baker, Malcolm P., Richard S. Ruback, and Aldo Sesia. "Pharmacyclics: Financing Research & Development." Harvard Business School Case 201-056, January 2001. (Revised July 2003.)
- Research Summary
Wall Street Research
By: Paul M. Healy
Wall Street research helps to support a well-functioning capital market by providing investors with information about investment opportunities, and corporate issuers with liquidity for their stocks. Yet surprisingly little is known about how Wall Street research... View Details